Home
Oxford Genetics Ltd.

Oxford Genetics Ltd. Market Share Analysis for June 2026

Get to know OXGENE, an Advanced Therapies company that supplies cutting edge solutions and services for breakthrough cell and gene therapies.

Science and Education > Biology

Domainoxfordgenetics.com

Year Founded2011

Employees51 - 200

Annual Revenue$10M - $15M

Oxford Genetics Ltd.

Oxford Genetics Ltd. (including company regionals)

oxfordgenetics.com

See more website traffic and engagement information

Oxford Genetics Ltd. Revenue up to June 2026 is 10M - 15M

revenue generated by Oxford Genetics Ltd. top domains

Oxford Genetics Ltd. top domains revenue over 3 years

Revenue for Oxford Genetics Ltd. top domains

oxfordgenetics.com10M - 15M

See more with Sales Intelligence

Total visits to Oxford Genetics Ltd.'s top domains

Understand Oxford Genetics Ltd. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Oxford Genetics Ltd.'s top domains

Analyze Oxford Genetics Ltd. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Oxford Genetics Ltd.'s top domains

See how Oxford Genetics Ltd. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Oxford Genetics Ltd. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Oxford Genetics Ltd.

These are the website technologies, by industry, used by Oxford Genetics Ltd. top domains

Payment & Currencies (7)

Cart Functionality

Widget (3)

reCAPTCHA

Email Services (2)

G Suite

Mobile (2)

Meta Viewport

More Technologies

7

See all

News & Signals from Oxford Genetics Ltd.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAldevron LLC partnered with Oxfordgenetics on Jan 1st '19.For instance, in January 2019, Aldevron announced an agreement with Oxford Genetics to bring a standardized range of its plasmids for lentiviral manufacturing into the market.